People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pivot Bio, Inc. | — | Biotech / Pharma | Growth/Late | $622.6M | $13.0B | 2018 |
Charles Cooper Rinzler at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Cooper Rinzler on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matt Ocko | 1 | 13 |
| John Hamer | 1 | 7 |
| Roger Wyse | 1 | 5 |
| Christopher Cooper Abbott | 1 | 1 |
| Ryan Cooper Rakestraw | 1 | 1 |
| Alvin Cooper Tamsir | 1 | 1 |
| Lisa Cooper Safarian | 1 | 1 |
| Dheeraj Cooper Mehta | 1 | 1 |
| Karsten Temme | 1 | 1 |
| Alvin Tamsir | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.